FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use
Share this article Share this article SAN DIEGO, March 5, 2021 /PRNewswire/ -- Cue Health Inc. (Cue) announced the healthcare technology company has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for over the counter sale of its fast, accurate, COVID-19 test, making it the nation's first molecular diagnostic test available to consumers without a prescription. The Cue COVID-19 Test for Home and Over The Counter (OTC) Use (Cue OTC Test) uses a lower nasal swab and delivers results in about 20 minutes to the user's mobile smart device. The Cue OTC Tes...
Source: prnewswire.com